Market Snapshot

Market Overview

Market Overview

Biomarkers, often referred to as molecular markers or signature molecules, are biological molecules found in blood, bodily fluids, or tissues that provide insights into normal or abnormal processes, conditions, or diseases. They play a pivotal role in assessing the body's response to treatments. Over the past 15–20 years, biomarkers have gained prominence in drug development and the broader cancer patient journey. They find applications in various drug development stages, including enrichment, stratification, patient selection, safety, efficacy assessment, and performance evaluation.

For instance, the utilization of biomarkers in oncology clinical trials has seen significant growth, with 55 percent of all oncology trials in 2018 incorporating biomarkers, compared to just 15 percent in 2000.

Segmentation by End-Users

The end-users of biomarkers encompass research and academic laboratories, biopharmaceutical and biotech companies, diagnostic centers, and others. Biopharmaceutical companies have integrated biomarker strategies into their research and commercial operations. These biomarkers help optimize targeted therapy portfolios, guide clinical development decisions, facilitate bio-specimen access and preservation, construct clinico-genomic datasets, segment commercial markets, formulate market access and pricing strategies for biomarker-driven therapies, and foster collaborations with academic and diagnostic partners.

Leading biopharmaceutical companies, such as Roche, Novartis, AstraZeneca, Bristol-Myers Squibb, Merck, and Pfizer, have prominently focused on biomarker trials during the period from 2000 to 2018. This emphasis likely stemmed from their commitment to targeted therapy and immunotherapy portfolios, as well as their specific disease area interests.

Segmentation by Geography

The global clinical biomarkers market is geographically classified into Europe, Asia Pacific, North America, Latin America, and the Middle East & Africa. North America emerges as a major hub for the clinical biomarkers market, with significant medical research taking place in the United States and Canada. The U.S. leads in biomedical research discoveries and research and development expenditures. It is the largest market for biopharmaceuticals globally and a leader in biopharmaceutical R&D.

Cancer incidence in the United States is high, with nearly 4 out of 10 individuals expected to develop cancer during their lifetimes. The U.S. Food and Drug Administration encourages the integration of biomarkers in medical product development and approval processes, facilitating monitoring and appropriate clinical use.

Overall, the extensive medical research, the presence of a well-established biopharmaceutical industry, and high cancer incidence rates position North America as a potential leading market for clinical biomarkers.

Uncover key market trends, investment insights, and global economic impacts driving this industry's growth
Download Free Overview Report

Porter 5

Market Segmentation

Company Performance

Financial values in the chart are available after report is purchased.

Our Company Coverage

Our comprehensive company performance report offers a detailed analysis of critical factors for our clients' industry insights. It covers key financial metrics, such as revenue, profit, and profit margin, providing a clear financial overview. We also assess the company's structure by identifying key subsidiaries and top industry competitors, conducting a thorough SWOT analysis to reveal strengths, weaknesses, opportunities, and threats. The report includes an in-depth income statement for financial assessment and a credit analysis for evaluating creditworthiness. Industry-specific data and benchmarks enable clients to compare performance, providing actionable insights for strategic decisions and competitive advantages.

Corporate Information

Main activities
Number of employees
Key executives
Company Description
Similar companies
Ownership details
Financial Performance Charts
Top Competitors
Similar companies
Ownership details
Financial Performance Charts
Top Competitors

Corporate Information

Income statement
Credit analysis
Credit analysis
Benchmark score

Depending on the size and type of the organisation we may also provide:

News: Business/financial results, investments and deals
Reports: Annual reports, broker reports
M&A: Information on past deals, deal intents
Discover the industry's latest trends, global economic factors, and impactful investments driving its expansion.
Download Free Sample
Download Free Sample

Table of Contents

Table of Contents

1. Research Methodology and Scope

2. Executive Summary

3. Impact of COVID-19 on Clinical Biomarkers Market

4. Market Dynamics

        4.1 Drivers

        4.2 Restraints

5. Competitive Landscape

        5.1 Key Strategies Adopted by Major Companies

        5.2 Company Share Analysis

6. Clinical Biomarkers Market Segmentation by Type

        6.1 Diagnostic Biomarkers

        6.2 Predictive Biomarkers

        6.3 Prognostic Biomarkers

7. Clinical Biomarkers Market Segmentation by Clinical Area

        7.1 Cancer Biomarkers

        7.2 Cardiac Biomarkers

        7.3 Neurological Biomarkers

        7.4 Infectious Disease

        7.5 Immunological Biomarkers

        7.6 Non-Invasive Prenatal Testing

        7.7 Other Clinical Areas

8. Clinical Biomarkers Market Segmentation by End-User

        8.1 Hospitals

        8.2 Central Laboratories

        8.3 Point-of-Care

        8.4 Clinics

        8.5 Academic Institutions

        8.6 Others

10. Clinical Biomarkers Market by Region

        9.1 North America

                 9.1.1 United States

                 9.1.2 Canada

                 9.1.3 Mexico

        9.2 Europe

                 9.2.1 United Kingdom

                 9.2.2 Spain

                 9.2.3 Italy

                 9.2.4 Germany

                 9.2.5 Russia

                 9.2.6 France

                 9.2.7 Netherlands

                 9.2.6 Rest of Europe

        9.3 Asia-Pacific

                 9.3.1 China

                 9.3.2 India

                 9.3.3 Japan

                 9.3.4 Australia

                 9.3.5 South Korea

                 9.3.6 Rest of Asia-Pacific

        9.4 South America

                 9.4.1 Brazil

                 9.4.2 Rest of South America

        9.5 Middle East and Africa

10. Company Profiles

        10.1 Abbott Laboratories

        10.2 Agilent Technologies

        10.3 Roche

        10.4 BioMérieux

        10.5 Bio-Rad Laboratories

        10.6 Enzo Biochem

        10.7 Hologic

        10.8 Illumina

        10.9 Alcediag

        10.10 Centogene

11. Appendix

Major Players

No items found.